Marin, G. H., Marin, L., Haag, G. O., Risso, P., & Errecalde, J. O. (2018). Erythropoietin treatment in chronic renal failure anaemia-biosimilar option in the rational use of medicine process in order to reduced public health economic burden. Web
Citación estilo ChicagoMarin, Gustavo Horacio, Lupe Marin, Griselda Octavia Haag, Paula Risso, and Jorge Oscar Errecalde. Erythropoietin Treatment in Chronic Renal Failure Anaemia-biosimilar Option in the Rational Use of Medicine Process in Order to Reduced Public Health Economic Burden. 2018.
Cita MLAMarin, Gustavo Horacio, et al. Erythropoietin Treatment in Chronic Renal Failure Anaemia-biosimilar Option in the Rational Use of Medicine Process in Order to Reduced Public Health Economic Burden. 2018.